Buy the Dip: Nike at a Decade-Plus Low with a Fat Yield and a Clear Recovery Path

Hook / Thesis

Nike is no longer the runaway growth story it was in 2020-2021, but the stock now sits near multi-year lows and yields a meaningful 3.66% on the current price. At $45.38 the market has priced in a protracted recovery: shares are over 75% below their 2021 highs and recently printed a 52-week low of $42.09 on 04/13/2026. That deep discount, combined with steady cash generation and an investment-grade looking balance sheet, makes Nike an actionable long with a defined risk-reward profile.

My trade: enter long at $45.38, size so that a stop at $40.00 limits position-level loss to your risk tolerance, and target $60.00 over a long-term horizon (180 trading days). The dividend payout - $0.41 per quarter, most recently paid on 04/01/2026 - provides an income cushion while the operational turnaround gets traction.

What Nike does and why the market should care

Nike, Inc. designs, develops, markets and sells athletic footwear, apparel and equipment across major global markets. It operates through North America, EMEA, Greater China and APLA segments, plus wholesale licensing and the Converse business. The brand still dominates U.S. youth and retail mindshare, and running and football product lines have shown pockets of strength even as international markets lag.

The market cares because Nike is large and liquid - market cap in the dataset is $67.19B - and it acts as a bellwether for global athletic footwear demand, retail channel dynamics (direct-to-consumer versus wholesale) and consumer spending trends. A sustained recovery at Nike would pull up suppliers, retailers and several sector peers; conversely, a deeper stumble would reinforce concerns about secular demand and margin pressure across the industry.

Key fundamentals and what the numbers say

Use the following as the core picture:

Those numbers tell a few important stories. First, valuation is compressed relative to the companys recent peak but not giveaway cheap on traditional multiples - P/E around 29x and EV/EBITDA near 19x imply the market still expects mediocre earnings recovery. Second, Nike remains a cash-generative business with $1.048B in free cash flow and a conservative-ish balance sheet (debt/equity 0.57). Third, the dividend yield of ~3.66% adds a valuation cushion and converts a volatile entry into an income plus capital appreciation trade.

Technical and sentiment backdrop

Technicals are supportive for a bounce trade: 10-day SMA is $43.78 and the 9-day EMA sits at $44.86 - both below current price - while RSI is 35.9, indicating the stock is near oversold territory but not deeply capitulated. Short interest runs in the 40-46M share range with days-to-cover around 2.5-3.1 on recent settlements, so a squeeze is possible but not imminent. Volume over the last month has been elevated relative to the stock's 30-day average, signaling distribution followed by opportunistic accumulation by longer-term players.

Valuation framing

At $67.19B market cap and P/S of ~1.41, Nike is trading at multiples consistent with a company expected to deliver slow top-line growth and margin recovery. Historically investors paid a premium for Nike's growth profile; today the premium has largely evaporated. That means the stock now offers a higher income yield and a lower growth premium, shifting the risk-reward in favor of patient, income-minded buyers.

To justify $60.00 (my target), Nike would need a combination of modest margin recovery, stabilization in Greater China, and accelerating wholesale sales - a scenario that restores investor confidence and moves the multiple from current mid-to-high-teens EV/EBITDA territory toward the low-20s on normalized EBITDA. Given the companys FCF base and brand moat, that outcome is plausible within 3-6 months if catalysts align.

Catalysts (what could drive the trade)

• Evidence of stabilization or improvement in Greater China sales - the market has priced in large declines; any data showing the downtrend easing would be a positive surprise.
• Continued wholesale re-engagement and faster product cycles that translate into stronger sell-through, particularly in North America and running categories.
• Margin relief via inventory reduction and lower tariffs or cost efficiencies that improve gross margin from recent pressured levels.
• Management commentary showing disciplined capital allocation - steady or increasing dividends and share repurchases would bolster confidence.
• Any sign of improved Converse performance or successful brand segmentation that adds incremental revenue without heavy markdowns.

Trade plan - entry, stop, target and horizon

Entry: Buy at $45.38.
Stop-loss: $40.00 - place a hard stop to protect capital in case the China weakness or margin pressure worsens.
Target: $60.00 - take full profits at this level or begin scaling out as price approaches. Consider partial profit-taking at $52.00 on way up to lock in gains.
Horizon: Long-term (180 trading days) - I expect the trade to play out across 3-6 months while the company digests inventory, fine-tunes product flow and benefits from any seasonal or promotional tailwinds. If you prefer shorter windows, a mid-term (45 trading days) play could work but expect higher volatility and a lower probability of hitting the full target.

Rationale for the stop and target: $40.00 lies comfortably below the recent 52-week low of $42.09 (04/13/2026), meaning a breach would signal continued deterioration and justify exit. The $60.00 target represents a reasonable recovery in earnings expectations and a partial multiple re-rating without requiring a return to 2025 highs.

Risks and counterarguments

Strong, specific risks to this trade - at least four worth considering:

• China demand remains weak. Management flagged a 20% revenue decline expectation in China in recent commentary - a deep and prolonged slump there would materially slow global recovery and compress multiples further.
• Margin pressure persists. Tariffs, input costs and elevated promotional activity can keep gross margin depressed and damage free cash flow and EPS, undermining valuation.
• Competition and market share loss. Smaller, faster competitors in performance and lifestyle footwear are taking share in key categories; if Nike cannot accelerate product innovation and speed to market, revenue recovery could stall.
• Dividend sustainability questions. While yield is attractive today, a protracted earnings decline or severe cash-flow hit could force management to cut or pause payouts - which would wipe out much of the yield-based comfort for income buyers.
• Macro risk. A consumer spending slowdown or recession would disproportionately hurt discretionary apparel and footwear sales and could drive the stock even lower.

Counterargument: The bears are reasonably loud and have data to support their case - flat revenues and a 35% net income drop in the most recent quarter show the company is not out of the woods. If earnings continue sliding into FY2027, multiples could compress further and this trade will underperform. That said, the company still generates over $1B in free cash flow, the balance sheet is manageable and the dividend provides income while you wait for recovery. In short: the bear case is credible and is priced into the current market level, but downside beyond the current low would require an outsized deterioration in fundamental performance.

What would change my mind

I will reassess the bullish stance if any of the following occur: a) management signals significant dividend cuts or a halt to buybacks, b) China deterioration accelerates beyond the current guidance and starts hitting North America via inventory glut, or c) gross margins compress further despite inventory reductions. Conversely, sustained sequential revenue growth in North America and stabilization in China with margin expansion would reinforce the bullish case and invite adding to the position.

Conclusion

Nike at $45.38 offers a compelling risk-reward for disciplined, income-oriented investors willing to accept near-term volatility. The 3.66% yield, $1.048B FCF and a manageable balance sheet form a base under the stock while management executes a turnaround in product and channel strategy. This is not a low-risk, immediate turnaround trade - its a patient, long-term recovery trade where an explicit stop at $40.00 limits downside and a $60.00 target captures a meaningful re-rating if catalysts fall into place over the next 3-6 months.

Key dates to watch

• Ex-dividend date 03/02/2026 and payable date 04/01/2026 - confirms managements commitment to the payout in the current environment.
• Next quarterly earnings and management commentary - any sign of stabilization in Greater China or margin improvement will be a near-term trigger.

Actionable summary

Buy NKE at $45.38, stop $40.00, target $60.00, horizon long-term (180 trading days). Size positions to your risk tolerance and be prepared for headline-driven volatility. If the company reports improved sell-through or margin signals, consider adding on strength; if problems intensify, honor the stop and re-evaluate from the sidelines.